Journal
ONCOGENE
Volume 24, Issue 22, Pages 3606-3618Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1208386
Keywords
YB-1; MVP; 5-fluorouracil; drug resistance
Ask authors/readers for more resources
Vaults have been suggested to play a direct role in multidrug resistance ( MDR) to anticancer drugs. The human major vault protein ( MVP) also known as lung resistance- related protein ( LRP) represents the predominant component of vaults that may be involved in the defense against xenobiotics. Here, we demonstrate that besides MDR- related cytostatics, also the non- MDR-related drug 5-fluorouracil ( 5- FU) was able to induce MVP mRNA and protein expression. Treatment with 5- FU amplified the binding activity and interaction of the transcription factor Y- box binding protein- 1 ( YB- 1) with the Y- box of the human MVP gene promoter in a time-dependent manner. 5- FU also induced reporter expressions driven by a panel of newly generated MVP promoter deletion mutants. Interestingly, stably YB- 1 overexpressing cell clones showed enhanced binding of YB- 1 to the Y- box motif, associated with enhanced basal as well as 5- FU- inducible MVP promoter- driven reporter expressions. Moreover, transduction of YB- 1 cDNA led to increased expression of endogenous MVP protein. Under physiological conditions, we observed a strong coexpression of MVP and YB- 1 in human colon carcinoma specimen. In summary, our data demonstrate a direct involvement of YB- 1 in controlling basal and 5- FU-induced MVP promoter activity. Therefore, YB- 1 is directly linked to MVP- mediated drug resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available